focus -WSS

focus

author：comprehensive 2025-10-01 12:35:38 - browse：7

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： HIV vaccine remains elusive. Immunologists keep trying new ideas

WSS

With measles on the rise, a personal story of a devastating disease

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

With measles on the rise, a personal story of a devastating disease

Dario to buy mental health app maker Twill in cash and stock deal

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Hepatitis C has a cure — but many Americans still lack access to it

Alabama frozen embryo ruling has major implications for IVF clinics

Walensky prepares to leave CDC — and Congress — behind

With competition flaring, obesity drug hits goal in liver disease study

Continuity nursing helped my family in our darkest PICU moments

NIH study of ME/CFS points to clear biological hallmarks

Medical leaders decry Supreme Court decision on affirmative action

Big Tobacco's 'harm reduction': Is it for real, or a sham?

The high cost of giving birth even with insurance

6 phony surgeries that take placebo to the extreme

explore

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

The Harvard botanist who searched for psychedelics in the Amazon

Antivenom research: Lessons from HIV applied in search for universal antidote

Criminal prosecution for violating HIPAA: an emerging threat

entertainment

Wikipedia

entertainment

entertainment